You searched for
Montelukast
SACAA Part 67 assessment
Acceptable with conditions / grounding period
Active ingredient(s)
Montelukast
Leukotriene receptor antagonist
Stabilisation period
At least 2 weeks stable and side-effect free
Guidance notes
Generally acceptable for well-controlled asthma or allergic rhinitis, but montelukast is recognised to cause neuropsychiatric effects — vivid dreams, sleep disturbance, anxiety and mood change. Requires a stable, side-effect-free period and DAME notification, and the underlying asthma must itself be certified.
Known SA brand names
Our DAME partners
Dr Berlize du Plessis
Senior DAME · MS213
Kenridge, Cape Town
Dr Brandon Head
Senior DAME · MS229
Sunninghill, Sandton
Dr Ernest Schutz
Senior DAME · MS028
Germiston
Dr Mariska van Tonder
Senior DAME · MS222
Somerset West
Dr Richard Albrecht
Senior DAME · MS074
Strubensvalley, Roodepoort
Dr. Schalk Reyneke
Senior DAME · MS123
Honeydew, Roodepoort
Possible acceptable alternatives (same therapeutic group)
- Fluticasone / Mometasone (nasal steroid)Flixonase, Nasonex, AvamysAcceptable
- Salbutamol (inhaled)Ventolin, Asthavent, VentezeConditional
Alternatives are informational only. The underlying medical condition must also be assessed by a DAME — a condition can ground you even when the medicine is acceptable.